The mammalian cell fermentation technology market is estimated to be worth US$ 45.9 billion in 2024. Between 2024 and 2034, the industry is expected to register a CAGR of 10%. The growing prevalence of chronic diseases and the growing aging population worldwide are driving demand for biopharmaceuticals.